Thornton, Karen

Thornton, Karen was paid $13.49M by Medicaid between Apr 2020 and Nov 2024, across 18 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 60% of everything it billed.

Compared with peers

Next to other Family Medicine Physician providers in New York

Rank by total paid#8 of 2,605

Median peer was paid$10K

This provider vs. median1,336×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2020	1,750	$50K
2021	4,141	$131K
2022	86,288	$1.36M
2023	390,931	$11.92M
2024incomplete	1,348	$32K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	60%	140,141	38,081	$8.09M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	20%	136,869	37,850	$2.66M
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	8.4%	41,100	27,364	$1.14M
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	5.3%	24,876	3,921	$714K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	3.8%	119,878	43,227	$517K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	12,076	9,147	$97K
99203	Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity	<1%	2,167	2,119	$81K
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	2,366	1,809	$53K
S9083	Global fee urgent care centers	<1%	511	471	$52K
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	<1%	2,121	1,836	$52K
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	<1%	366	346	$12K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	<1%	526	489	$12K

6 more codes

99204	Doctor's office visit, new patient (more involved)	<1%	197	$7K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	164	$2K
36415	Collection of venous blood by venipuncture	<1%	595	$977.94
99243		<1%	45	$746.04
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	31	$302.42
S9088	Services provided in an urgent care center (list in addition to code for service)	0%	429	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.